Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Explorative Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

NCT01256372 is registered in ClinicalTrials.gov with Action Pharma A/S as lead sponsor.

NCT NCT01256372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Explorative Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
Lead sponsor
Action Pharma A/S
Phase
Phase 2
Overall status
Completed
Start date
October 31, 2010
Completion date
August 31, 2011
Enrollment
77 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic aneurysm, cardiac surgery, coronary artery bypass, kidney diseases, valve surgery